CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 645 of 652
Non-Antibody Products
Page 645 of 652
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| Y-27632 (hydrochloride) | A potent, ATP-competitive inhibitor of ROCKs including p160ROCK (Ki = 140… | 50 mg | 10005583-50 | More Info |
| Y-33075 (hydrochloride) | An inhibitor of ROCK2 (IC50 = 3.6 nM); selective for ROCK2 over PKC and Ca… | 1 mg | 36216-1 | More Info |
| Y-33075 (hydrochloride) | An inhibitor of ROCK2 (IC50 = 3.6 nM); selective for ROCK2 over PKC and Ca… | 10 mg | 36216-10 | More Info |
| Y-33075 (hydrochloride) | An inhibitor of ROCK2 (IC50 = 3.6 nM); selective for ROCK2 over PKC and Ca… | 25 mg | 36216-25 | More Info |
| Y-33075 (hydrochloride) | An inhibitor of ROCK2 (IC50 = 3.6 nM); selective for ROCK2 over PKC and Ca… | 5 mg | 36216-5 | More Info |
| YIL 781 (hydrochloride) | An antagonist of GHS-R1a (Ki = 0.017 µM); selective for GHS-R1a over… | 1 mg | 29217-1 | More Info |
| YIL 781 (hydrochloride) | An antagonist of GHS-R1a (Ki = 0.017 µM); selective for GHS-R1a over… | 10 mg | 29217-10 | More Info |
| YIL 781 (hydrochloride) | An antagonist of GHS-R1a (Ki = 0.017 µM); selective for GHS-R1a over… | 25 mg | 29217-25 | More Info |
| YIL 781 (hydrochloride) | An antagonist of GHS-R1a (Ki = 0.017 µM); selective for GHS-R1a over… | 5 mg | 29217-5 | More Info |
| YK-009 | An ionizable cationic lipid (pKa = 6.512); administration of SARS-CoV-2 Om… | 1 mg | 38282-1 | More Info |
| YK-009 | An ionizable cationic lipid (pKa = 6.512); administration of SARS-CoV-2 Om… | 10 mg | 38282-10 | More Info |
| YK-009 | An ionizable cationic lipid (pKa = 6.512); administration of SARS-CoV-2 Om… | 5 mg | 38282-5 | More Info |
| YK-11 | A partial agonist of the androgen receptor; activates androgen receptor tr… | 10 mg | 9003137-10 | More Info |
| YK-11 | A partial agonist of the androgen receptor; activates androgen receptor tr… | 100 mg | 9003137-100 | More Info |
| YK-11 | A partial agonist of the androgen receptor; activates androgen receptor tr… | 50 mg | 9003137-50 | More Info |
| YK-3-237 | An inhibitor of tubulin polymerization and an activator of SIRT1; inhibits… | 1 mg | 21516-1 | More Info |
| YK-3-237 | An inhibitor of tubulin polymerization and an activator of SIRT1; inhibits… | 10 mg | 21516-10 | More Info |
| YK-3-237 | An inhibitor of tubulin polymerization and an activator of SIRT1; inhibits… | 25 mg | 21516-25 | More Info |
| YK-3-237 | An inhibitor of tubulin polymerization and an activator of SIRT1; inhibits… | 5 mg | 21516-5 | More Info |
| YKL-05-099 | An inhibitor of SIK2 (IC50 = 0.04 µM for the human enzyme); selectiv… | 10 mg | 36116-10 | More Info |
| YKL-05-099 | An inhibitor of SIK2 (IC50 = 0.04 µM for the human enzyme); selectiv… | 25 mg | 36116-25 | More Info |
| YKL-05-099 | An inhibitor of SIK2 (IC50 = 0.04 µM for the human enzyme); selectiv… | 5 mg | 36116-5 | More Info |
| YKL-05-099 | An inhibitor of SIK2 (IC50 = 0.04 µM for the human enzyme); selectiv… | 50 mg | 36116-50 | More Info |
| YL-109 | An anticancer agent; inhibits the proliferation of MCF-7 and MDA-MB-231 ce… | 10 mg | 30290-10 | More Info |
| YL-109 | An anticancer agent; inhibits the proliferation of MCF-7 and MDA-MB-231 ce… | 25 mg | 30290-25 | More Info |
| YL-109 | An anticancer agent; inhibits the proliferation of MCF-7 and MDA-MB-231 ce… | 5 mg | 30290-5 | More Info |
| YL-109 | An anticancer agent; inhibits the proliferation of MCF-7 and MDA-MB-231 ce… | 50 mg | 30290-50 | More Info |
| YLF-466D | An AMPK activator at a concentration of 150 µM in platelets; inhibit… | 1 mg | 19475-1 | More Info |
| YLF-466D | An AMPK activator at a concentration of 150 µM in platelets; inhibit… | 10 mg | 19475-10 | More Info |
| YLF-466D | An AMPK activator at a concentration of 150 µM in platelets; inhibit… | 5 mg | 19475-5 | More Info |
| YM-155 | A small molecule that suppresses transactivation of survivin through direc… | 1 mg | 11490-1 | More Info |
| YM-155 | A small molecule that suppresses transactivation of survivin through direc… | 10 mg | 11490-10 | More Info |
| YM-155 | A small molecule that suppresses transactivation of survivin through direc… | 25 mg | 11490-25 | More Info |
| YM-155 | A small molecule that suppresses transactivation of survivin through direc… | 5 mg | 11490-5 | More Info |
| YM-201636 | A cell-permeable and selective inhibitor of PIKfyve (IC50 = 33 nM); revers… | 1 mg | 13576-1 | More Info |
| YM-201636 | A cell-permeable and selective inhibitor of PIKfyve (IC50 = 33 nM); revers… | 10 mg | 13576-10 | More Info |
| YM-201636 | A cell-permeable and selective inhibitor of PIKfyve (IC50 = 33 nM); revers… | 5 mg | 13576-5 | More Info |
| YM-254890 | A cyclic depsipeptide Gαq / 11 inhibitor; inhibits Gαq / 11-me… | 1 mg | 29735-1 | More Info |
| YM-26734 | A competitive sPLA2-IIA inhibitor with IC50 values of 80, 30, 120, 110, 52… | 1 mg | 17631-1 | More Info |
| YM-26734 | A competitive sPLA2-IIA inhibitor with IC50 values of 80, 30, 120, 110, 52… | 10 mg | 17631-10 | More Info |
| YM-26734 | A competitive sPLA2-IIA inhibitor with IC50 values of 80, 30, 120, 110, 52… | 25 mg | 17631-25 | More Info |
| YM-26734 | A competitive sPLA2-IIA inhibitor with IC50 values of 80, 30, 120, 110, 52… | 5 mg | 17631-5 | More Info |
| YM-53601 | A squalene synthase inhibitor (IC50s = 79 and 90 nM in HepG2 cells and rat… | 1 mg | 18113-1 | More Info |
| YM-53601 | A squalene synthase inhibitor (IC50s = 79 and 90 nM in HepG2 cells and rat… | 5 mg | 18113-5 | More Info |
| YM-53601 | A squalene synthase inhibitor (IC50s = 79 and 90 nM in HepG2 cells and rat… | 500 µg | 18113-500 | More Info |
| YM-58483 | A potent inhibitor of calcium release-activated calcium channels in lympho… | 1 mg | 13246-1 | More Info |
| YM-58483 | A potent inhibitor of calcium release-activated calcium channels in lympho… | 10 mg | 13246-10 | More Info |
| YM-58483 | A potent inhibitor of calcium release-activated calcium channels in lympho… | 25 mg | 13246-25 | More Info |
| YM-58483 | A potent inhibitor of calcium release-activated calcium channels in lympho… | 5 mg | 13246-5 | More Info |
| YM-90709 | An IL-5 receptor antagonist (IC50s = 1 and 0.57 µM for peripheral hu… | 10 mg | 23448-10 | More Info |
| YM-90709 | An IL-5 receptor antagonist (IC50s = 1 and 0.57 µM for peripheral hu… | 25 mg | 23448-25 | More Info |
| YM-90709 | An IL-5 receptor antagonist (IC50s = 1 and 0.57 µM for peripheral hu… | 5 mg | 23448-5 | More Info |
| YM-976 | A PDE4 inhibitor (IC50 = 2.2 nM for the human peripheral leukocyte enzyme)… | 10 mg | 29529-10 | More Info |
| YM-976 | A PDE4 inhibitor (IC50 = 2.2 nM for the human peripheral leukocyte enzyme)… | 25 mg | 29529-25 | More Info |
| YM-976 | A PDE4 inhibitor (IC50 = 2.2 nM for the human peripheral leukocyte enzyme)… | 5 mg | 29529-5 | More Info |
| YM-976 | A PDE4 inhibitor (IC50 = 2.2 nM for the human peripheral leukocyte enzyme)… | 50 mg | 29529-50 | More Info |
| YM-155 (chloride) | A survivin inhibitor; inhibits survivin promoter activity in a reporter as… | 10 mg | 36827-10 | More Info |
| YM-155 (chloride) | A survivin inhibitor; inhibits survivin promoter activity in a reporter as… | 25 mg | 36827-25 | More Info |
| YM-155 (chloride) | A survivin inhibitor; inhibits survivin promoter activity in a reporter as… | 5 mg | 36827-5 | More Info |
| YM-155 (chloride) | A survivin inhibitor; inhibits survivin promoter activity in a reporter as… | 50 mg | 36827-50 | More Info |
| YM-298198 (hydrochloride) | A non-competitive antagonist of mGluR1 (Ki = 19 nM); selective for mGluR1… | 1 mg | 22925-1 | More Info |
| YM-298198 (hydrochloride) | A non-competitive antagonist of mGluR1 (Ki = 19 nM); selective for mGluR1… | 10 mg | 22925-10 | More Info |
| YM-298198 (hydrochloride) | A non-competitive antagonist of mGluR1 (Ki = 19 nM); selective for mGluR1… | 25 mg | 22925-25 | More Info |
| YM-298198 (hydrochloride) | A non-competitive antagonist of mGluR1 (Ki = 19 nM); selective for mGluR1… | 5 mg | 22925-5 | More Info |
| YM-90K (hydrochloride hydrate) | An AMPA receptor antagonist (Ki = 0.084 µM in a radioligand binding… | 1 mg | 30683-1 | More Info |
| YM-90K (hydrochloride hydrate) | An AMPA receptor antagonist (Ki = 0.084 µM in a radioligand binding… | 10 mg | 30683-10 | More Info |
| YM-90K (hydrochloride hydrate) | An AMPA receptor antagonist (Ki = 0.084 µM in a radioligand binding… | 25 mg | 30683-25 | More Info |
| YM-90K (hydrochloride hydrate) | An AMPA receptor antagonist (Ki = 0.084 µM in a radioligand binding… | 5 mg | 30683-5 | More Info |
| YMU1 | A thymidylate kinase inhibitor (IC50 = 610 nM); selective for thymidylate… | 10 mg | 21981-10 | More Info |
| YMU1 | A thymidylate kinase inhibitor (IC50 = 610 nM); selective for thymidylate… | 5 mg | 21981-5 | More Info |
| Yoda1 | A Piezo1 channel agonist (EC50s = 17.1 and 26.6 µM for murine and hu… | 1 mg | 21904-1 | More Info |
| Yoda1 | A Piezo1 channel agonist (EC50s = 17.1 and 26.6 µM for murine and hu… | 10 mg | 21904-10 | More Info |
| Yoda1 | A Piezo1 channel agonist (EC50s = 17.1 and 26.6 µM for murine and hu… | 25 mg | 21904-25 | More Info |
| Yoda1 | A Piezo1 channel agonist (EC50s = 17.1 and 26.6 µM for murine and hu… | 5 mg | 21904-5 | More Info |
| Yohimbine (hydrochloride) | A natural alkaloid that has antagonist activity at α2-adrenergic rec… | 1 g | 19869-1 | More Info |
| Yohimbine (hydrochloride) | A natural alkaloid that has antagonist activity at α2-adrenergic rec… | 10 g | 19869-10 | More Info |
| Yohimbine (hydrochloride) | A natural alkaloid that has antagonist activity at α2-adrenergic rec… | 5 g | 19869-5 | More Info |
| Yohimbine (hydrochloride) | A natural alkaloid that has antagonist activity at α2-adrenergic rec… | 500 mg | 19869-500 | More Info |
| 740 Y-P (trifluoroacetate salt) | A PI3K activator; increases phosphorylation of PI3K, mTOR, and GSK3β… | 1 mg | 22598-1 | More Info |
| 740 Y-P (trifluoroacetate salt) | A PI3K activator; increases phosphorylation of PI3K, mTOR, and GSK3β… | 500 µg | 22598-500 | More Info |
| YQ-128 | An NLRP3 inflammasome inhibitor (IC50 = 0.3 µM); inhibits LPS- and A… | 1 mg | 36451-1 | More Info |
| YQ-128 | An NLRP3 inflammasome inhibitor (IC50 = 0.3 µM); inhibits LPS- and A… | 10 mg | 36451-10 | More Info |
| YQ-128 | An NLRP3 inflammasome inhibitor (IC50 = 0.3 µM); inhibits LPS- and A… | 25 mg | 36451-25 | More Info |
| YQ-128 | An NLRP3 inflammasome inhibitor (IC50 = 0.3 µM); inhibits LPS- and A… | 5 mg | 36451-5 | More Info |
| YS-121 | A dual inhibitor of mPGES-1 (IC50 = 3.9 µM ) and 5-LO (IC50 = 4.1 &m… | 1 mg | 13665-1 | More Info |
| YS-121 | A dual inhibitor of mPGES-1 (IC50 = 3.9 µM ) and 5-LO (IC50 = 4.1 &m… | 10 mg | 13665-10 | More Info |
| YS-121 | A dual inhibitor of mPGES-1 (IC50 = 3.9 µM ) and 5-LO (IC50 = 4.1 &m… | 25 mg | 13665-25 | More Info |
| YS-121 | A dual inhibitor of mPGES-1 (IC50 = 3.9 µM ) and 5-LO (IC50 = 4.1 &m… | 5 mg | 13665-5 | More Info |
| YS-49 | A platelet aggregation inhibitor; inhibits ADP-, collagen-, or epinephrine… | 1 mg | 30970-1 | More Info |
| YS-49 | A platelet aggregation inhibitor; inhibits ADP-, collagen-, or epinephrine… | 10 mg | 30970-10 | More Info |
| YS-49 | A platelet aggregation inhibitor; inhibits ADP-, collagen-, or epinephrine… | 25 mg | 30970-25 | More Info |
| YS-49 | A platelet aggregation inhibitor; inhibits ADP-, collagen-, or epinephrine… | 5 mg | 30970-5 | More Info |
| YS-035 (hydrochloride) | A verapamil derivative that dose-dependently blocks calcium uptake via Na+… | 10 mg | 17705-10 | More Info |
| YS-035 (hydrochloride) | A verapamil derivative that dose-dependently blocks calcium uptake via Na+… | 50 mg | 17705-50 | More Info |
| YSK05 | An ionizable cationic amino lipid (apparent pKa = ~6.5); has been used in… | 10 mg | 35786-10 | More Info |
| YSK05 | An ionizable cationic amino lipid (apparent pKa = ~6.5); has been used in… | 25 mg | 35786-25 | More Info |
| YSK05 | An ionizable cationic amino lipid (apparent pKa = ~6.5); has been used in… | 5 mg | 35786-5 | More Info |
| YTHDC2 (human, recombinant) | Source: Recombinant N-terminal GST-tagged YTHDC2 purified from E. coli &bu… | 100 µg | 26344-100 | More Info |
| YTHDF2 (human recombinant) | Source: Recombinant N-terminal GST-tagged YTHDF2 purified from E. coli &bu… | 100 µg | 26345-100 | More Info |
| YU238259 | An inhibitor of homology-dependent DNA repair; lethal to BRCA2-/- but not… | 1 mg | 25452-1 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile